nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1B—obesity	0.448	1	CbGaD
Frovatriptan—CYP1A2—Phentermine—obesity	0.0711	0.292	CbGbCtD
Frovatriptan—CYP1A2—Phenylpropanolamine—obesity	0.0678	0.278	CbGbCtD
Frovatriptan—CYP1A2—Bupropion—obesity	0.0604	0.248	CbGbCtD
Frovatriptan—CYP1A2—Cimetidine—obesity	0.0444	0.182	CbGbCtD
Frovatriptan—Tinnitus—Sibutramine—obesity	0.000257	0.00128	CcSEcCtD
Frovatriptan—Dizziness—Diethylpropion—obesity	0.000255	0.00127	CcSEcCtD
Frovatriptan—Epistaxis—Bupropion—obesity	0.000253	0.00126	CcSEcCtD
Frovatriptan—Polyuria—Topiramate—obesity	0.000252	0.00125	CcSEcCtD
Frovatriptan—Sinusitis—Bupropion—obesity	0.000251	0.00125	CcSEcCtD
Frovatriptan—Diarrhoea—Cimetidine—obesity	0.000251	0.00125	CcSEcCtD
Frovatriptan—Mental disorder—Orlistat—obesity	0.00025	0.00124	CcSEcCtD
Frovatriptan—Malnutrition—Orlistat—obesity	0.000248	0.00123	CcSEcCtD
Frovatriptan—Vascular purpura—Topiramate—obesity	0.000248	0.00123	CcSEcCtD
Frovatriptan—Chills—Sibutramine—obesity	0.000248	0.00123	CcSEcCtD
Frovatriptan—Arrhythmia—Sibutramine—obesity	0.000246	0.00122	CcSEcCtD
Frovatriptan—Eye pain—Topiramate—obesity	0.000245	0.00122	CcSEcCtD
Frovatriptan—Vomiting—Diethylpropion—obesity	0.000245	0.00122	CcSEcCtD
Frovatriptan—Flatulence—Orlistat—obesity	0.000245	0.00121	CcSEcCtD
Frovatriptan—Dysgeusia—Orlistat—obesity	0.000243	0.00121	CcSEcCtD
Frovatriptan—Dizziness—Cimetidine—obesity	0.000243	0.0012	CcSEcCtD
Frovatriptan—Haemoglobin—Bupropion—obesity	0.000242	0.0012	CcSEcCtD
Frovatriptan—Headache—Diethylpropion—obesity	0.000242	0.0012	CcSEcCtD
Frovatriptan—Rhinitis—Bupropion—obesity	0.000241	0.0012	CcSEcCtD
Frovatriptan—Haemorrhage—Bupropion—obesity	0.000241	0.00119	CcSEcCtD
Frovatriptan—Malnutrition—Sibutramine—obesity	0.00024	0.00119	CcSEcCtD
Frovatriptan—Back pain—Orlistat—obesity	0.00024	0.00119	CcSEcCtD
Frovatriptan—Hypoaesthesia—Bupropion—obesity	0.000239	0.00119	CcSEcCtD
Frovatriptan—Pharyngitis—Bupropion—obesity	0.000239	0.00119	CcSEcCtD
Frovatriptan—Muscle spasms—Orlistat—obesity	0.000239	0.00119	CcSEcCtD
Frovatriptan—Urinary tract disorder—Bupropion—obesity	0.000238	0.00118	CcSEcCtD
Frovatriptan—Hot flush—Topiramate—obesity	0.000237	0.00118	CcSEcCtD
Frovatriptan—Flatulence—Sibutramine—obesity	0.000237	0.00118	CcSEcCtD
Frovatriptan—Urethral disorder—Bupropion—obesity	0.000236	0.00117	CcSEcCtD
Frovatriptan—Amnesia—Topiramate—obesity	0.000236	0.00117	CcSEcCtD
Frovatriptan—Tension—Sibutramine—obesity	0.000236	0.00117	CcSEcCtD
Frovatriptan—Dysgeusia—Sibutramine—obesity	0.000235	0.00117	CcSEcCtD
Frovatriptan—Menopausal symptoms—Topiramate—obesity	0.000235	0.00117	CcSEcCtD
Frovatriptan—Nervousness—Sibutramine—obesity	0.000233	0.00116	CcSEcCtD
Frovatriptan—Vomiting—Cimetidine—obesity	0.000233	0.00116	CcSEcCtD
Frovatriptan—Thirst—Topiramate—obesity	0.000233	0.00116	CcSEcCtD
Frovatriptan—Back pain—Sibutramine—obesity	0.000232	0.00115	CcSEcCtD
Frovatriptan—Visual impairment—Bupropion—obesity	0.000232	0.00115	CcSEcCtD
Frovatriptan—Muscle spasms—Sibutramine—obesity	0.000231	0.00115	CcSEcCtD
Frovatriptan—Ill-defined disorder—Orlistat—obesity	0.00023	0.00114	CcSEcCtD
Frovatriptan—Headache—Cimetidine—obesity	0.00023	0.00114	CcSEcCtD
Frovatriptan—Purpura—Topiramate—obesity	0.00023	0.00114	CcSEcCtD
Frovatriptan—Nausea—Diethylpropion—obesity	0.000229	0.00114	CcSEcCtD
Frovatriptan—Hypoglycaemia—Topiramate—obesity	0.000227	0.00113	CcSEcCtD
Frovatriptan—Tremor—Sibutramine—obesity	0.000225	0.00112	CcSEcCtD
Frovatriptan—Tinnitus—Bupropion—obesity	0.000224	0.00111	CcSEcCtD
Frovatriptan—Malaise—Orlistat—obesity	0.000224	0.00111	CcSEcCtD
Frovatriptan—Flushing—Bupropion—obesity	0.000223	0.00111	CcSEcCtD
Frovatriptan—Vertigo—Orlistat—obesity	0.000223	0.00111	CcSEcCtD
Frovatriptan—Ill-defined disorder—Sibutramine—obesity	0.000223	0.00111	CcSEcCtD
Frovatriptan—Pain in extremity—Topiramate—obesity	0.000222	0.0011	CcSEcCtD
Frovatriptan—Osteoarthritis—Topiramate—obesity	0.000222	0.0011	CcSEcCtD
Frovatriptan—Agitation—Sibutramine—obesity	0.000221	0.0011	CcSEcCtD
Frovatriptan—Palpitations—Orlistat—obesity	0.000219	0.00109	CcSEcCtD
Frovatriptan—Affect lability—Topiramate—obesity	0.000218	0.00108	CcSEcCtD
Frovatriptan—Migraine—Topiramate—obesity	0.000218	0.00108	CcSEcCtD
Frovatriptan—Nausea—Cimetidine—obesity	0.000218	0.00108	CcSEcCtD
Frovatriptan—Malaise—Sibutramine—obesity	0.000217	0.00108	CcSEcCtD
Frovatriptan—Chills—Bupropion—obesity	0.000216	0.00107	CcSEcCtD
Frovatriptan—Vertigo—Sibutramine—obesity	0.000216	0.00107	CcSEcCtD
Frovatriptan—Syncope—Sibutramine—obesity	0.000215	0.00107	CcSEcCtD
Frovatriptan—Convulsion—Orlistat—obesity	0.000215	0.00107	CcSEcCtD
Frovatriptan—Arrhythmia—Bupropion—obesity	0.000215	0.00107	CcSEcCtD
Frovatriptan—Palpitations—Sibutramine—obesity	0.000212	0.00105	CcSEcCtD
Frovatriptan—Myalgia—Orlistat—obesity	0.000211	0.00105	CcSEcCtD
Frovatriptan—Chest pain—Orlistat—obesity	0.000211	0.00105	CcSEcCtD
Frovatriptan—Loss of consciousness—Sibutramine—obesity	0.000211	0.00105	CcSEcCtD
Frovatriptan—Mental disorder—Bupropion—obesity	0.000211	0.00105	CcSEcCtD
Frovatriptan—Anxiety—Orlistat—obesity	0.000211	0.00105	CcSEcCtD
Frovatriptan—Mood swings—Topiramate—obesity	0.00021	0.00104	CcSEcCtD
Frovatriptan—Malnutrition—Bupropion—obesity	0.000209	0.00104	CcSEcCtD
Frovatriptan—Discomfort—Orlistat—obesity	0.000209	0.00104	CcSEcCtD
Frovatriptan—Ataxia—Topiramate—obesity	0.000208	0.00103	CcSEcCtD
Frovatriptan—Convulsion—Sibutramine—obesity	0.000208	0.00103	CcSEcCtD
Frovatriptan—Dry mouth—Orlistat—obesity	0.000207	0.00103	CcSEcCtD
Frovatriptan—Flatulence—Bupropion—obesity	0.000206	0.00102	CcSEcCtD
Frovatriptan—Dehydration—Topiramate—obesity	0.000206	0.00102	CcSEcCtD
Frovatriptan—Tension—Bupropion—obesity	0.000205	0.00102	CcSEcCtD
Frovatriptan—Dysgeusia—Bupropion—obesity	0.000205	0.00102	CcSEcCtD
Frovatriptan—Chest pain—Sibutramine—obesity	0.000204	0.00102	CcSEcCtD
Frovatriptan—Arthralgia—Sibutramine—obesity	0.000204	0.00102	CcSEcCtD
Frovatriptan—Myalgia—Sibutramine—obesity	0.000204	0.00102	CcSEcCtD
Frovatriptan—Anxiety—Sibutramine—obesity	0.000204	0.00101	CcSEcCtD
Frovatriptan—Nervousness—Bupropion—obesity	0.000203	0.00101	CcSEcCtD
Frovatriptan—Anaphylactic shock—Orlistat—obesity	0.000203	0.00101	CcSEcCtD
Frovatriptan—Back pain—Bupropion—obesity	0.000203	0.00101	CcSEcCtD
Frovatriptan—Discomfort—Sibutramine—obesity	0.000202	0.001	CcSEcCtD
Frovatriptan—Muscle spasms—Bupropion—obesity	0.000201	0.001	CcSEcCtD
Frovatriptan—Dry mouth—Sibutramine—obesity	0.0002	0.000993	CcSEcCtD
Frovatriptan—Confusional state—Sibutramine—obesity	0.000198	0.000982	CcSEcCtD
Frovatriptan—Tremor—Bupropion—obesity	0.000196	0.000974	CcSEcCtD
Frovatriptan—Anaphylactic shock—Sibutramine—obesity	0.000196	0.000974	CcSEcCtD
Frovatriptan—Hyperhidrosis—Orlistat—obesity	0.000196	0.000972	CcSEcCtD
Frovatriptan—Muscular weakness—Topiramate—obesity	0.000195	0.00097	CcSEcCtD
Frovatriptan—Ill-defined disorder—Bupropion—obesity	0.000194	0.000965	CcSEcCtD
Frovatriptan—Shock—Sibutramine—obesity	0.000193	0.000958	CcSEcCtD
Frovatriptan—Agitation—Bupropion—obesity	0.000192	0.000956	CcSEcCtD
Frovatriptan—Dysphagia—Topiramate—obesity	0.000191	0.000951	CcSEcCtD
Frovatriptan—Tachycardia—Sibutramine—obesity	0.000191	0.00095	CcSEcCtD
Frovatriptan—Hyperhidrosis—Sibutramine—obesity	0.000189	0.000941	CcSEcCtD
Frovatriptan—Malaise—Bupropion—obesity	0.000189	0.000938	CcSEcCtD
Frovatriptan—Vertigo—Bupropion—obesity	0.000188	0.000934	CcSEcCtD
Frovatriptan—Syncope—Bupropion—obesity	0.000188	0.000933	CcSEcCtD
Frovatriptan—Anorexia—Sibutramine—obesity	0.000187	0.000928	CcSEcCtD
Frovatriptan—Sweating increased—Topiramate—obesity	0.000186	0.000926	CcSEcCtD
Frovatriptan—Palpitations—Bupropion—obesity	0.000185	0.000919	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Orlistat—obesity	0.000185	0.000916	CcSEcCtD
Frovatriptan—Loss of consciousness—Bupropion—obesity	0.000184	0.000914	CcSEcCtD
Frovatriptan—Insomnia—Orlistat—obesity	0.000183	0.00091	CcSEcCtD
Frovatriptan—Paraesthesia—Orlistat—obesity	0.000182	0.000903	CcSEcCtD
Frovatriptan—Convulsion—Bupropion—obesity	0.000181	0.000901	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Sibutramine—obesity	0.000179	0.000887	CcSEcCtD
Frovatriptan—Dyspepsia—Orlistat—obesity	0.000178	0.000885	CcSEcCtD
Frovatriptan—Myalgia—Bupropion—obesity	0.000178	0.000885	CcSEcCtD
Frovatriptan—Arthralgia—Bupropion—obesity	0.000178	0.000885	CcSEcCtD
Frovatriptan—Chest pain—Bupropion—obesity	0.000178	0.000885	CcSEcCtD
Frovatriptan—Anxiety—Bupropion—obesity	0.000178	0.000882	CcSEcCtD
Frovatriptan—Insomnia—Sibutramine—obesity	0.000177	0.000881	CcSEcCtD
Frovatriptan—Pollakiuria—Topiramate—obesity	0.000177	0.000878	CcSEcCtD
Frovatriptan—Discomfort—Bupropion—obesity	0.000176	0.000875	CcSEcCtD
Frovatriptan—Decreased appetite—Orlistat—obesity	0.000176	0.000874	CcSEcCtD
Frovatriptan—Paraesthesia—Sibutramine—obesity	0.000176	0.000874	CcSEcCtD
Frovatriptan—Dyspnoea—Sibutramine—obesity	0.000175	0.000868	CcSEcCtD
Frovatriptan—Fatigue—Orlistat—obesity	0.000175	0.000867	CcSEcCtD
Frovatriptan—Dry mouth—Bupropion—obesity	0.000174	0.000866	CcSEcCtD
Frovatriptan—Somnolence—Sibutramine—obesity	0.000174	0.000865	CcSEcCtD
Frovatriptan—Pain—Orlistat—obesity	0.000173	0.00086	CcSEcCtD
Frovatriptan—Dyspepsia—Sibutramine—obesity	0.000173	0.000857	CcSEcCtD
Frovatriptan—Confusional state—Bupropion—obesity	0.000172	0.000856	CcSEcCtD
Frovatriptan—Anaphylactic shock—Bupropion—obesity	0.000171	0.000849	CcSEcCtD
Frovatriptan—Decreased appetite—Sibutramine—obesity	0.00017	0.000846	CcSEcCtD
Frovatriptan—Depression—Topiramate—obesity	0.00017	0.000845	CcSEcCtD
Frovatriptan—Shock—Bupropion—obesity	0.000168	0.000835	CcSEcCtD
Frovatriptan—Constipation—Sibutramine—obesity	0.000168	0.000833	CcSEcCtD
Frovatriptan—Pain—Sibutramine—obesity	0.000168	0.000833	CcSEcCtD
Frovatriptan—Feeling abnormal—Orlistat—obesity	0.000167	0.000829	CcSEcCtD
Frovatriptan—Tachycardia—Bupropion—obesity	0.000167	0.000828	CcSEcCtD
Frovatriptan—Stomatitis—Topiramate—obesity	0.000166	0.000826	CcSEcCtD
Frovatriptan—Conjunctivitis—Topiramate—obesity	0.000166	0.000824	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Orlistat—obesity	0.000166	0.000823	CcSEcCtD
Frovatriptan—Hyperhidrosis—Bupropion—obesity	0.000165	0.00082	CcSEcCtD
Frovatriptan—Anorexia—Bupropion—obesity	0.000163	0.000809	CcSEcCtD
Frovatriptan—Feeling abnormal—Sibutramine—obesity	0.000162	0.000802	CcSEcCtD
Frovatriptan—Epistaxis—Topiramate—obesity	0.000161	0.0008	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Sibutramine—obesity	0.00016	0.000796	CcSEcCtD
Frovatriptan—Sinusitis—Topiramate—obesity	0.00016	0.000795	CcSEcCtD
Frovatriptan—Abdominal pain—Orlistat—obesity	0.00016	0.000795	CcSEcCtD
Frovatriptan—Body temperature increased—Orlistat—obesity	0.00016	0.000795	CcSEcCtD
Frovatriptan—Bradycardia—Topiramate—obesity	0.000156	0.000775	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Bupropion—obesity	0.000156	0.000773	CcSEcCtD
Frovatriptan—Body temperature increased—Sibutramine—obesity	0.000155	0.00077	CcSEcCtD
Frovatriptan—Abdominal pain—Sibutramine—obesity	0.000155	0.00077	CcSEcCtD
Frovatriptan—Insomnia—Bupropion—obesity	0.000155	0.000768	CcSEcCtD
Frovatriptan—Haemoglobin—Topiramate—obesity	0.000154	0.000765	CcSEcCtD
Frovatriptan—Rhinitis—Topiramate—obesity	0.000154	0.000763	CcSEcCtD
Frovatriptan—Paraesthesia—Bupropion—obesity	0.000153	0.000762	CcSEcCtD
Frovatriptan—Haemorrhage—Topiramate—obesity	0.000153	0.000761	CcSEcCtD
Frovatriptan—Hypoaesthesia—Topiramate—obesity	0.000152	0.000757	CcSEcCtD
Frovatriptan—Dyspnoea—Bupropion—obesity	0.000152	0.000757	CcSEcCtD
Frovatriptan—Pharyngitis—Topiramate—obesity	0.000152	0.000755	CcSEcCtD
Frovatriptan—Somnolence—Bupropion—obesity	0.000152	0.000755	CcSEcCtD
Frovatriptan—Urinary tract disorder—Topiramate—obesity	0.000151	0.000752	CcSEcCtD
Frovatriptan—Dyspepsia—Bupropion—obesity	0.00015	0.000747	CcSEcCtD
Frovatriptan—Urethral disorder—Topiramate—obesity	0.00015	0.000746	CcSEcCtD
Frovatriptan—Hypersensitivity—Orlistat—obesity	0.000149	0.000741	CcSEcCtD
Frovatriptan—Decreased appetite—Bupropion—obesity	0.000149	0.000738	CcSEcCtD
Frovatriptan—Visual impairment—Topiramate—obesity	0.000148	0.000733	CcSEcCtD
Frovatriptan—Fatigue—Bupropion—obesity	0.000147	0.000732	CcSEcCtD
Frovatriptan—Pain—Bupropion—obesity	0.000146	0.000726	CcSEcCtD
Frovatriptan—Constipation—Bupropion—obesity	0.000146	0.000726	CcSEcCtD
Frovatriptan—Asthenia—Orlistat—obesity	0.000145	0.000722	CcSEcCtD
Frovatriptan—Hypersensitivity—Sibutramine—obesity	0.000144	0.000717	CcSEcCtD
Frovatriptan—Pruritus—Orlistat—obesity	0.000143	0.000712	CcSEcCtD
Frovatriptan—Tinnitus—Topiramate—obesity	0.000143	0.00071	CcSEcCtD
Frovatriptan—Flushing—Topiramate—obesity	0.000142	0.000706	CcSEcCtD
Frovatriptan—Feeling abnormal—Bupropion—obesity	0.000141	0.000699	CcSEcCtD
Frovatriptan—Asthenia—Sibutramine—obesity	0.000141	0.000698	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Bupropion—obesity	0.00014	0.000694	CcSEcCtD
Frovatriptan—Pruritus—Sibutramine—obesity	0.000139	0.000689	CcSEcCtD
Frovatriptan—Diarrhoea—Orlistat—obesity	0.000139	0.000688	CcSEcCtD
Frovatriptan—Chills—Topiramate—obesity	0.000137	0.000683	CcSEcCtD
Frovatriptan—Abdominal pain—Bupropion—obesity	0.000135	0.000671	CcSEcCtD
Frovatriptan—Body temperature increased—Bupropion—obesity	0.000135	0.000671	CcSEcCtD
Frovatriptan—Mental disorder—Topiramate—obesity	0.000134	0.000667	CcSEcCtD
Frovatriptan—Diarrhoea—Sibutramine—obesity	0.000134	0.000666	CcSEcCtD
Frovatriptan—Dizziness—Orlistat—obesity	0.000134	0.000665	CcSEcCtD
Frovatriptan—Malnutrition—Topiramate—obesity	0.000133	0.000663	CcSEcCtD
Frovatriptan—Flatulence—Topiramate—obesity	0.000131	0.000653	CcSEcCtD
Frovatriptan—Tension—Topiramate—obesity	0.000131	0.00065	CcSEcCtD
Frovatriptan—Dysgeusia—Topiramate—obesity	0.000131	0.000649	CcSEcCtD
Frovatriptan—Dizziness—Sibutramine—obesity	0.00013	0.000644	CcSEcCtD
Frovatriptan—Nervousness—Topiramate—obesity	0.00013	0.000643	CcSEcCtD
Frovatriptan—Back pain—Topiramate—obesity	0.000129	0.000641	CcSEcCtD
Frovatriptan—Vomiting—Orlistat—obesity	0.000129	0.00064	CcSEcCtD
Frovatriptan—Muscle spasms—Topiramate—obesity	0.000128	0.000637	CcSEcCtD
Frovatriptan—Headache—Orlistat—obesity	0.000127	0.00063	CcSEcCtD
Frovatriptan—Hypersensitivity—Bupropion—obesity	0.000126	0.000625	CcSEcCtD
Frovatriptan—Tremor—Topiramate—obesity	0.000125	0.000621	CcSEcCtD
Frovatriptan—Vomiting—Sibutramine—obesity	0.000125	0.000619	CcSEcCtD
Frovatriptan—Ill-defined disorder—Topiramate—obesity	0.000124	0.000615	CcSEcCtD
Frovatriptan—Headache—Sibutramine—obesity	0.000123	0.00061	CcSEcCtD
Frovatriptan—Asthenia—Bupropion—obesity	0.000123	0.000609	CcSEcCtD
Frovatriptan—Agitation—Topiramate—obesity	0.000123	0.000609	CcSEcCtD
Frovatriptan—Pruritus—Bupropion—obesity	0.000121	0.0006	CcSEcCtD
Frovatriptan—Nausea—Orlistat—obesity	0.00012	0.000598	CcSEcCtD
Frovatriptan—Malaise—Topiramate—obesity	0.00012	0.000597	CcSEcCtD
Frovatriptan—Vertigo—Topiramate—obesity	0.00012	0.000595	CcSEcCtD
Frovatriptan—Syncope—Topiramate—obesity	0.00012	0.000594	CcSEcCtD
Frovatriptan—Palpitations—Topiramate—obesity	0.000118	0.000585	CcSEcCtD
Frovatriptan—Loss of consciousness—Topiramate—obesity	0.000117	0.000582	CcSEcCtD
Frovatriptan—Diarrhoea—Bupropion—obesity	0.000117	0.000581	CcSEcCtD
Frovatriptan—Nausea—Sibutramine—obesity	0.000116	0.000578	CcSEcCtD
Frovatriptan—Convulsion—Topiramate—obesity	0.000116	0.000574	CcSEcCtD
Frovatriptan—Arthralgia—Topiramate—obesity	0.000114	0.000564	CcSEcCtD
Frovatriptan—Myalgia—Topiramate—obesity	0.000114	0.000564	CcSEcCtD
Frovatriptan—Chest pain—Topiramate—obesity	0.000114	0.000564	CcSEcCtD
Frovatriptan—Anxiety—Topiramate—obesity	0.000113	0.000562	CcSEcCtD
Frovatriptan—Dizziness—Bupropion—obesity	0.000113	0.000561	CcSEcCtD
Frovatriptan—Discomfort—Topiramate—obesity	0.000112	0.000557	CcSEcCtD
Frovatriptan—Dry mouth—Topiramate—obesity	0.000111	0.000552	CcSEcCtD
Frovatriptan—Confusional state—Topiramate—obesity	0.00011	0.000545	CcSEcCtD
Frovatriptan—Vomiting—Bupropion—obesity	0.000109	0.00054	CcSEcCtD
Frovatriptan—Shock—Topiramate—obesity	0.000107	0.000532	CcSEcCtD
Frovatriptan—Headache—Bupropion—obesity	0.000107	0.000532	CcSEcCtD
Frovatriptan—Tachycardia—Topiramate—obesity	0.000106	0.000528	CcSEcCtD
Frovatriptan—Hyperhidrosis—Topiramate—obesity	0.000105	0.000523	CcSEcCtD
Frovatriptan—Anorexia—Topiramate—obesity	0.000104	0.000515	CcSEcCtD
Frovatriptan—Nausea—Bupropion—obesity	0.000102	0.000504	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Topiramate—obesity	9.92e-05	0.000493	CcSEcCtD
Frovatriptan—Insomnia—Topiramate—obesity	9.85e-05	0.000489	CcSEcCtD
Frovatriptan—Paraesthesia—Topiramate—obesity	9.78e-05	0.000486	CcSEcCtD
Frovatriptan—Dyspnoea—Topiramate—obesity	9.71e-05	0.000482	CcSEcCtD
Frovatriptan—Somnolence—Topiramate—obesity	9.68e-05	0.000481	CcSEcCtD
Frovatriptan—Dyspepsia—Topiramate—obesity	9.58e-05	0.000476	CcSEcCtD
Frovatriptan—Decreased appetite—Topiramate—obesity	9.46e-05	0.00047	CcSEcCtD
Frovatriptan—Fatigue—Topiramate—obesity	9.39e-05	0.000466	CcSEcCtD
Frovatriptan—Pain—Topiramate—obesity	9.31e-05	0.000462	CcSEcCtD
Frovatriptan—Constipation—Topiramate—obesity	9.31e-05	0.000462	CcSEcCtD
Frovatriptan—Feeling abnormal—Topiramate—obesity	8.97e-05	0.000446	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Topiramate—obesity	8.9e-05	0.000442	CcSEcCtD
Frovatriptan—Abdominal pain—Topiramate—obesity	8.61e-05	0.000427	CcSEcCtD
Frovatriptan—Body temperature increased—Topiramate—obesity	8.61e-05	0.000427	CcSEcCtD
Frovatriptan—Hypersensitivity—Topiramate—obesity	8.02e-05	0.000398	CcSEcCtD
Frovatriptan—Asthenia—Topiramate—obesity	7.81e-05	0.000388	CcSEcCtD
Frovatriptan—Pruritus—Topiramate—obesity	7.7e-05	0.000383	CcSEcCtD
Frovatriptan—Diarrhoea—Topiramate—obesity	7.45e-05	0.00037	CcSEcCtD
Frovatriptan—Dizziness—Topiramate—obesity	7.2e-05	0.000358	CcSEcCtD
Frovatriptan—Vomiting—Topiramate—obesity	6.92e-05	0.000344	CcSEcCtD
Frovatriptan—Headache—Topiramate—obesity	6.82e-05	0.000339	CcSEcCtD
Frovatriptan—Nausea—Topiramate—obesity	6.47e-05	0.000321	CcSEcCtD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT2—obesity	1.21e-05	0.000113	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CB—obesity	1.2e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD2—obesity	1.2e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CG—obesity	1.2e-05	0.000112	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	1.2e-05	0.000112	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GCG—obesity	1.19e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PTPN1—obesity	1.19e-05	0.000111	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UCP2—obesity	1.18e-05	0.00011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ECHS1—obesity	1.18e-05	0.00011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HSD11B1—obesity	1.18e-05	0.00011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UCP3—obesity	1.18e-05	0.00011	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CD—obesity	1.16e-05	0.000108	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADH1B—obesity	1.16e-05	0.000108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCD—obesity	1.15e-05	0.000108	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—obesity	1.14e-05	0.000106	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARGC1B—obesity	1.14e-05	0.000106	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPAM—obesity	1.14e-05	0.000106	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ACSL1—obesity	1.14e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—obesity	1.14e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRL—obesity	1.14e-05	0.000106	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCD—obesity	1.13e-05	0.000105	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—obesity	1.13e-05	0.000105	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—C3—obesity	1.13e-05	0.000105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STK11—obesity	1.12e-05	0.000105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—obesity	1.11e-05	0.000104	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLG—obesity	1.11e-05	0.000103	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—obesity	1.11e-05	0.000103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PCK1—obesity	1.11e-05	0.000103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HADH—obesity	1.11e-05	0.000103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FADS1—obesity	1.11e-05	0.000103	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—RHOA—obesity	1.1e-05	0.000103	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—C3—obesity	1.1e-05	0.000103	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT2—obesity	1.09e-05	0.000102	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3R1—obesity	1.09e-05	0.000102	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—obesity	1.09e-05	0.000102	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FOXO3—obesity	1.08e-05	0.000101	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB2—obesity	1.08e-05	0.000101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ACP5—obesity	1.08e-05	0.0001	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS2—obesity	1.07e-05	0.0001	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGT—obesity	1.07e-05	0.0001	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—obesity	1.06e-05	9.91e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SOCS1—obesity	1.06e-05	9.91e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CD—obesity	1.05e-05	9.82e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS2—obesity	1.05e-05	9.81e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—obesity	1.05e-05	9.8e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—obesity	1.05e-05	9.8e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGT—obesity	1.05e-05	9.8e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SOCS3—obesity	1.05e-05	9.79e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—G6PD—obesity	1.05e-05	9.79e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CAV1—obesity	1.04e-05	9.71e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—obesity	1.04e-05	9.69e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SREBF2—obesity	1.04e-05	9.67e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HK1—obesity	1.04e-05	9.67e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—obesity	1.03e-05	9.66e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—obesity	1.03e-05	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—obesity	1.03e-05	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNB3—obesity	1.03e-05	9.58e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CAV1—obesity	1.02e-05	9.51e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—obesity	1.02e-05	9.49e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TYK2—obesity	1.01e-05	9.45e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CB—obesity	1.01e-05	9.42e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF2—obesity	1.01e-05	9.41e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RHOA—obesity	1e-05	9.37e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ESR1—obesity	1e-05	9.36e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPA—obesity	1e-05	9.34e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GNAS—obesity	9.99e-06	9.33e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3R1—obesity	9.93e-06	9.27e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCB—obesity	9.9e-06	9.24e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—F2—obesity	9.9e-06	9.24e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ESR1—obesity	9.81e-06	9.16e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPIN1—obesity	9.78e-06	9.14e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOB—obesity	9.78e-06	9.13e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—BAD—obesity	9.78e-06	9.13e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—F2—obesity	9.69e-06	9.05e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCB—obesity	9.69e-06	9.05e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—obesity	9.61e-06	8.98e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA5—obesity	9.58e-06	8.95e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—BAD—obesity	9.58e-06	8.94e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL5—obesity	9.55e-06	8.92e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CG—obesity	9.47e-06	8.85e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS1—obesity	9.36e-06	8.74e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LPL—obesity	9.34e-06	8.72e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—obesity	9.31e-06	8.69e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CG—obesity	9.28e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FOXO1—obesity	9.27e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RPS6KB1—obesity	9.26e-06	8.64e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS1—obesity	9.17e-06	8.56e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CB—obesity	9.16e-06	8.56e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CLOCK—obesity	9.14e-06	8.54e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC22A1—obesity	9.14e-06	8.54e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—obesity	9.12e-06	8.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—obesity	9.04e-06	8.44e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—obesity	9.02e-06	8.42e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—obesity	9.02e-06	8.42e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—obesity	8.97e-06	8.37e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GLP1R—obesity	8.91e-06	8.32e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SULT2A1—obesity	8.91e-06	8.32e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—obesity	8.83e-06	8.24e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—obesity	8.82e-06	8.24e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—obesity	8.78e-06	8.2e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DPYD—obesity	8.77e-06	8.19e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—obesity	8.67e-06	8.1e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT2—obesity	8.67e-06	8.09e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—obesity	8.64e-06	8.07e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCD—obesity	8.61e-06	8.04e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—obesity	8.49e-06	7.93e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT2—obesity	8.49e-06	7.92e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PRKAR2B—obesity	8.44e-06	7.88e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—obesity	8.42e-06	7.86e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—C3—obesity	8.41e-06	7.85e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DCN—obesity	8.38e-06	7.82e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CD—obesity	8.33e-06	7.78e-05	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—obesity	8.25e-06	7.7e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—obesity	8.24e-06	7.69e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	8.23e-06	7.69e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CD—obesity	8.15e-06	7.61e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CPT1A—obesity	8.15e-06	7.61e-05	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—obesity	8.08e-06	7.54e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—obesity	8.06e-06	7.53e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TYK2—obesity	8.01e-06	7.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS2—obesity	8e-06	7.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NAMPT—obesity	7.99e-06	7.46e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGT—obesity	7.99e-06	7.46e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	7.95e-06	7.42e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RHOA—obesity	7.95e-06	7.42e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCK—obesity	7.94e-06	7.42e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LIPC—obesity	7.94e-06	7.42e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOC3—obesity	7.89e-06	7.37e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3R1—obesity	7.86e-06	7.34e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—obesity	7.86e-06	7.34e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TYK2—obesity	7.84e-06	7.33e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	7.84e-06	7.32e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—obesity	7.83e-06	7.31e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—obesity	7.83e-06	7.31e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RHOA—obesity	7.78e-06	7.27e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CAV1—obesity	7.76e-06	7.24e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—obesity	7.74e-06	7.23e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—obesity	7.7e-06	7.19e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3R1—obesity	7.7e-06	7.19e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CETP—obesity	7.66e-06	7.16e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SDC1—obesity	7.58e-06	7.08e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—obesity	7.49e-06	6.99e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ESR1—obesity	7.47e-06	6.98e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C3—obesity	7.45e-06	6.96e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—F2—obesity	7.38e-06	6.89e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCB—obesity	7.38e-06	6.89e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SCARB1—obesity	7.34e-06	6.85e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—obesity	7.33e-06	6.85e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BAD—obesity	7.3e-06	6.81e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MTOR—obesity	7.26e-06	6.78e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CB—obesity	7.26e-06	6.78e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	7.24e-06	6.76e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	7.14e-06	6.67e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SREBF1—obesity	7.12e-06	6.65e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MTOR—obesity	7.11e-06	6.64e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CB—obesity	7.11e-06	6.64e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CG—obesity	7.07e-06	6.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS1—obesity	6.98e-06	6.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT2—obesity	6.93e-06	6.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.83e-06	6.38e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FASN—obesity	6.78e-06	6.33e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BCHE—obesity	6.75e-06	6.31e-05	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—obesity	6.74e-06	6.29e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—obesity	6.73e-06	6.28e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—obesity	6.69e-06	6.25e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—obesity	6.63e-06	6.19e-05	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—obesity	6.6e-06	6.16e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—obesity	6.58e-06	6.15e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2E1—obesity	6.51e-06	6.08e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—obesity	6.49e-06	6.06e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—obesity	6.47e-06	6.04e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT2—obesity	6.46e-06	6.04e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NQO1—obesity	6.44e-06	6.02e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—obesity	6.31e-06	5.89e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	6.31e-06	5.89e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	6.25e-06	5.84e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CD—obesity	6.21e-06	5.8e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—obesity	6.18e-06	5.77e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC2A4—obesity	6.18e-06	5.77e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCG—obesity	6.18e-06	5.77e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—obesity	6.15e-06	5.75e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—obesity	6.14e-06	5.74e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—obesity	6.14e-06	5.73e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—obesity	6.12e-06	5.71e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYCS—obesity	6.1e-06	5.69e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—obesity	6.01e-06	5.61e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—obesity	5.99e-06	5.59e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GGT1—obesity	5.98e-06	5.59e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT1—obesity	5.98e-06	5.59e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TYK2—obesity	5.98e-06	5.58e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RHOA—obesity	5.93e-06	5.53e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NCOA1—obesity	5.89e-06	5.5e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3R1—obesity	5.87e-06	5.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—obesity	5.87e-06	5.48e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—STK11—obesity	5.81e-06	5.42e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP19A1—obesity	5.81e-06	5.42e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—obesity	5.61e-06	5.24e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—obesity	5.59e-06	5.22e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—obesity	5.49e-06	5.13e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MTOR—obesity	5.41e-06	5.06e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CB—obesity	5.41e-06	5.06e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COMT—obesity	5.4e-06	5.04e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNB3—obesity	5.32e-06	4.97e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARGC1A—obesity	5.32e-06	4.97e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—obesity	5.3e-06	4.95e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—obesity	5.21e-06	4.87e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—obesity	5.2e-06	4.86e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GNAS—obesity	5.18e-06	4.84e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—obesity	5.1e-06	4.77e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—obesity	5.09e-06	4.75e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOB—obesity	5.08e-06	4.74e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—obesity	5.03e-06	4.69e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—obesity	4.95e-06	4.62e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPL—obesity	4.85e-06	4.53e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—obesity	4.73e-06	4.42e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—obesity	4.71e-06	4.39e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD36—obesity	4.6e-06	4.3e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—obesity	4.58e-06	4.27e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—obesity	4.56e-06	4.26e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—obesity	4.42e-06	4.13e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—obesity	4.36e-06	4.07e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—obesity	4.33e-06	4.05e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARA—obesity	4.28e-06	4e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—obesity	4.18e-06	3.91e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AGT—obesity	4.15e-06	3.87e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—obesity	4.06e-06	3.79e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAV1—obesity	4.02e-06	3.76e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—obesity	4.02e-06	3.75e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—obesity	3.92e-06	3.66e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—obesity	3.89e-06	3.63e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—obesity	3.88e-06	3.62e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.85e-06	3.59e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—obesity	3.84e-06	3.58e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CG—obesity	3.67e-06	3.42e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—obesity	3.61e-06	3.38e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—obesity	3.54e-06	3.31e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—obesity	3.54e-06	3.3e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—obesity	3.49e-06	3.26e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—obesity	3.47e-06	3.24e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—obesity	3.3e-06	3.08e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CD—obesity	3.22e-06	3.01e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—obesity	3.18e-06	2.97e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—obesity	3.04e-06	2.84e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3R1—obesity	3.04e-06	2.84e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—obesity	2.92e-06	2.73e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CB—obesity	2.81e-06	2.62e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—obesity	2.78e-06	2.6e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—obesity	2.7e-06	2.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—obesity	1.71e-06	1.6e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—obesity	1.4e-06	1.31e-05	CbGpPWpGaD
